Study Protocol: Global Research Initiative on the Neurophysiology of Schizophrenia (GRINS) project
- PMID: 38858652
- PMCID: PMC11165775
- DOI: 10.1186/s12888-024-05882-1
Study Protocol: Global Research Initiative on the Neurophysiology of Schizophrenia (GRINS) project
Abstract
Background: Objective and quantifiable markers are crucial for developing novel therapeutics for mental disorders by 1) stratifying clinically similar patients with different underlying neurobiological deficits and 2) objectively tracking disease trajectory and treatment response. Schizophrenia is often confounded with other psychiatric disorders, especially bipolar disorder, if based on cross-sectional symptoms. Awake and sleep EEG have shown promise in identifying neurophysiological differences as biomarkers for schizophrenia. However, most previous studies, while useful, were conducted in European and American populations, had small sample sizes, and utilized varying analytic methods, limiting comprehensive analyses or generalizability to diverse human populations. Furthermore, the extent to which wake and sleep neurophysiology metrics correlate with each other and with symptom severity or cognitive impairment remains unresolved. Moreover, how these neurophysiological markers compare across psychiatric conditions is not well characterized. The utility of biomarkers in clinical trials and practice would be significantly advanced by well-powered transdiagnostic studies. The Global Research Initiative on the Neurophysiology of Schizophrenia (GRINS) project aims to address these questions through a large, multi-center cohort study involving East Asian populations. To promote transparency and reproducibility, we describe the protocol for the GRINS project.
Methods: The research procedure consists of an initial screening interview followed by three subsequent sessions: an introductory interview, an evaluation visit, and an overnight neurophysiological recording session. Data from multiple domains, including demographic and clinical characteristics, behavioral performance (cognitive tasks, motor sequence tasks), and neurophysiological metrics (both awake and sleep electroencephalography), are collected by research groups specialized in each domain.
Conclusion: Pilot results from the GRINS project demonstrate the feasibility of this study protocol and highlight the importance of such research, as well as its potential to study a broader range of patients with psychiatric conditions. Through GRINS, we are generating a valuable dataset across multiple domains to identify neurophysiological markers of schizophrenia individually and in combination. By applying this protocol to related mental disorders often confounded with each other, we can gather information that offers insight into the neurophysiological characteristics and underlying mechanisms of these severe conditions, informing objective diagnosis, stratification for clinical research, and ultimately, the development of better-targeted treatment matching in the clinic.
Keywords: Biomarkers; Bipolar disorder; Brain dynamics; Event-related potential; Neurophysiological mechanism; Psychiatric disorders; Schizophrenia; Sleep EEG.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
[Neurophysiology of psychiatric disorders: building a national high-density electroencephalography platform].Med Sci (Paris). 2025 May;41(5):516-524. doi: 10.1051/medsci/2025076. Epub 2025 May 26. Med Sci (Paris). 2025. PMID: 40418014 French.
-
Neurophysiological explorations across the spectrum of psychosis, autism, and depression, during wakefulness and sleep: protocol of a prospective case-control transdiagnostic multimodal study (DEMETER).BMC Psychiatry. 2023 Nov 21;23(1):860. doi: 10.1186/s12888-023-05347-x. BMC Psychiatry. 2023. PMID: 37990173 Free PMC article.
-
Sleep spindles as neurophysiological biomarkers of schizophrenia.Eur J Neurosci. 2024 Apr;59(8):1907-1917. doi: 10.1111/ejn.16178. Epub 2023 Oct 26. Eur J Neurosci. 2024. PMID: 37885306 Review.
-
Neurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls--first steps in development of a biomarker.BMC Med. 2015 Nov 2;13:276. doi: 10.1186/s12916-015-0516-z. BMC Med. 2015. PMID: 26525736 Free PMC article.
-
A review of recent literature employing electroencephalographic techniques to study the pathophysiology, phenomenology, and treatment response of schizophrenia.Curr Psychiatry Rep. 2013 Sep;15(9):388. doi: 10.1007/s11920-013-0388-x. Curr Psychiatry Rep. 2013. PMID: 23933976 Review.
Cited by
-
Biomarkers in schizophrenia - past, present and future.Rom J Morphol Embryol. 2025 Jan-Mar;66(1):69-79. doi: 10.47162/RJME.66.1.06. Rom J Morphol Embryol. 2025. PMID: 40384193 Free PMC article. Review.
References
-
- Chang WC, Wong CSM, Chen EYH, Lam LCW, Chan WC, Ng RMK, Hung SF, Cheung EFC, Sham PC, Chiu HFK, et al. Lifetime prevalence and correlates of schizophrenia-spectrum, affective, and other non-affective psychotic disorders in the Chinese adult population. Schizophr Bull. 2017;43(6):1280–1290. doi: 10.1093/schbul/sbx056. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical